Plasmalex expands its offering with strategic acquisition of COAT-X

Switzerland, May 1, 2024 –  One year after the launch of Plasmalex, merging Europlasma and CPI, Plasmalex announces the further extension of its portfolio with the acquisition of Switzerland-based company COAT-X SA (  

The launch of Plasmalex was the result of the merger of renowned plasma technology companies Europlasma and CPI. This union has allowed Plasmalex to combine efforts and bring a comprehensive range of innovative plasma treatment solutions, for both vacuum and atmospheric plasma applications.

The addition of  the world’s tightest implantable multilayer COAT-X thin films to Plasmalex’ portfolio with a unique range of parylene, ALD and multilayer barrier solutions and equipment, means a significant expansion of our offering. As of May 1, Plasmalex will thereby offer a comprehensive range of surface functionalization and protection solutions.

As both companies are similarly technology-driven, R&D and IP development-focused, COAT-X CEO Andreas Hogg is delighted that his company finds its home in a stable group with leading innovations at an industrial scale. “Our COAT-X multi-layer thin film technology is unique for its superior hermeticity and minimal volume utilization, making it ideal for a wide range of applications across various industries. COAT-X is ISO 13485 certified and is therefore also allowed to coat medical devices for legal manufacturers. This new leverage of the acquisition will help our portfolio further grow,” he says.

Tim Beulens, Vice President at  Plasmalex underlines; “At Plasmalex, our mission remains the same: to assist customers, in expanding into new segments by providing them with innovative and high-quality solutions. With this addition, we are furthering our commitment to meeting customer’s unique needs and delivering the best possible solutions to help them succeed in several applications.

Read the full release.

Link to the Coat-X website